Cargando…
Serpin peptidase inhibitor clade A member 1-overexpression in gastric cancer promotes tumor progression in vitro and is associated with poor prognosis
Gastric cancer is the second most common cause of cancer-associated death in Asia. The incidence and mortality rates of gastric cancer have markedly increased in the past few decades. Therefore, the identification of novel gastric cancer biomarkers are needed to determine prognosis. The role of serp...
Autores principales: | Jiang, Longchang, Hu, Liangbiao George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520747/ https://www.ncbi.nlm.nih.gov/pubmed/33014156 http://dx.doi.org/10.3892/ol.2020.12141 |
Ejemplares similares
-
Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer
por: Kwon, C H, et al.
Publicado: (2014) -
Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients
por: Luo, Dingyuan, et al.
Publicado: (2017) -
High expression level of serpin peptidase inhibitor clade E member 2 is associated with poor prognosis in lung adenocarcinoma
por: Dokuni, Ryota, et al.
Publicado: (2020) -
Knockdown of serpin peptidase inhibitor clade C member 1 inhibits the growth of nasopharyngeal carcinoma cells
por: Xu, Jin, et al.
Publicado: (2019) -
SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer
por: Chen, Shujia, et al.
Publicado: (2022)